기자가 쓴 기사 더보기

[편집자 주 - 너무 어린 아이들이 강력한 향정신성 의약품에 쉽게 노출되어 있다는 기사입니다]
At 18 months, Kyle Warren started taking a daily antipsychotic drug on the orders of a pediatrician to quell the boy's severe tempter tantrums.
Thus began a troubled toddler's journey from one doctor to another, from one diagnosis to another, involving even more drugs. Autism, bipolar disorder, hyperactivity, insomnia, oppositional defiant disorder. The boy's daily pill regimen multiplied: the antipsychotic Risperdal [리스페달], the antidepressant Prozac [프로작], two sleeping medicines and one for attention-deficit disorder. All by the time he was 3.
He was sedated, drooling and overweight from the side effects of the antipsychotic medicine. Although his mother, Brandy Warren, had been at her "wit's end" when she resorted to the drug treatment, she began to worry about Kyle's altered personality.
"All I had was a medicated little boy," Ms. Warren said. "I didn't have my son. It's like, you'd look into his eyes, and you would just see just blankness."
Today, Kyle, 6, is in his forth week of first grade, scoring high marks on his first tests. He is rambunctious and much thinner. Weaned off the drugs through a program affiliated with Tulane University in New Orleans [U.S.A.] that is aimed at helping low-income families whose children have mental health problems, Kyle now laughs easily and teases his family.
Ms. Warren and Kyle's new doctors point to his remarkable progress - and a more common diagnosis for children of attention-deficit hyperactivity disorder - as proof that he should have never been prescribed such powerful drugs in the first place.
| 인기기사 | 더보기 + |
| 1 | 상장 제약바이오기업 3Q 평균 매출총이익...전년비 코스피 23.6%, 코스닥 16.2%↑ |
| 2 | 혈관·뼈 건강 지킴이 '고함량 초임계 비타민K2'…약사가 주목하는 이유는 |
| 3 | 화장품 기업 80개사 3Q 누적 해외매출 및 수출 평균 1157억…전년비 20.5%↑ |
| 4 | 상장 제약바이오기업 3Q 평균 영업이익...전년비 코스피 63.7%, 코스닥 34.3%↑ |
| 5 | "세계 최고 학술지 네이처 열었다" 이노크라스, 암 정밀의료 새 기준 제시 |
| 6 | 내년부터 AI 화장품 이미지·영상에 'AI 생성물' 표시 의무화 |
| 7 | 아로마티카, 블랙 프라이데이 아마존 매출 급성장… 역대 최대 실적 달성 |
| 8 | [약업분석] 엘앤씨바이오, '인체조직이식재' 3Q 누적매출 396억…전년比 17%↑ |
| 9 | 보로노이, 'VRN10' 임상 1상 데이터 공개..."초기 용량부터 항종양 효과 확인" |
| 10 | 상장 제약바이오기업 3Q 평균 순이익...전년비 코스피 126.3%, 코스닥 13.3%↑ |
| 인터뷰 | 더보기 + |
| PEOPLE | 더보기 + |
| 컬쳐/클래시그널 | 더보기 + |

[편집자 주 - 너무 어린 아이들이 강력한 향정신성 의약품에 쉽게 노출되어 있다는 기사입니다]
At 18 months, Kyle Warren started taking a daily antipsychotic drug on the orders of a pediatrician to quell the boy's severe tempter tantrums.
Thus began a troubled toddler's journey from one doctor to another, from one diagnosis to another, involving even more drugs. Autism, bipolar disorder, hyperactivity, insomnia, oppositional defiant disorder. The boy's daily pill regimen multiplied: the antipsychotic Risperdal [리스페달], the antidepressant Prozac [프로작], two sleeping medicines and one for attention-deficit disorder. All by the time he was 3.
He was sedated, drooling and overweight from the side effects of the antipsychotic medicine. Although his mother, Brandy Warren, had been at her "wit's end" when she resorted to the drug treatment, she began to worry about Kyle's altered personality.
"All I had was a medicated little boy," Ms. Warren said. "I didn't have my son. It's like, you'd look into his eyes, and you would just see just blankness."
Today, Kyle, 6, is in his forth week of first grade, scoring high marks on his first tests. He is rambunctious and much thinner. Weaned off the drugs through a program affiliated with Tulane University in New Orleans [U.S.A.] that is aimed at helping low-income families whose children have mental health problems, Kyle now laughs easily and teases his family.
Ms. Warren and Kyle's new doctors point to his remarkable progress - and a more common diagnosis for children of attention-deficit hyperactivity disorder - as proof that he should have never been prescribed such powerful drugs in the first place.